Screener
Sarepta Therapeutics, Inc. SRPT Business Segments — Facility And Technology Related Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:FacilityAndTechnologyRelatedExpenses.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Up-front and collaboration license fees | — | — | 50,000 | 583,787 |
| Manufacturing expenses | 1,837 | 80,685 | 21,595 | 148,150 |
| Clinical trial expenses | 23,102 | 33,511 | 41,406 | 66,658 |
| Facility- and technology-related expenses (excluding depreciation and amortization) | 23,890 | 28,580 | 46,832 | 56,237 |
| Research and development- other (excluding non-cash items) (1) | 19,847 | 31,843 | 38,518 | 60,314 |
| Selling, general and administrative- other (excluding non-cash items) (2) | 42,462 | 56,322 | 82,655 | 107,464 |
| Roche collaboration reimbursement | (7,169) | (25,689) | (15,358) | (54,170) |
| Other segment items (3) | (709) | (1,314) | (2,515) | (3,223) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — facility and technology related expenses of $23.89M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses decreased by 16.4% year-over-year, from $28.58M to $23.89M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses has grown at a 14.1% compound annual growth rate (CAGR), from $71.7M to $106.46M.
- What does business segments — facility and technology related expenses mean?
- Covers the overhead costs associated with maintaining physical facilities and the technological infrastructure required to support segment operations. This metric highlights the fixed cost burden and digital investment levels of the business unit.
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude